✦ LIBER ✦

Antiproliferative effects of rapamycin as a single agent and in combination with carboplatin and paclitaxel in head and neck cancer cell lines

✍ Scribed by Nasredine Aissat; Christophe Le Tourneau; Aïda Ghoul; Maria Serova; Ivan Bieche; François Lokiec; Eric Raymond; Sandrine Faivre

Publisher: Springer
Year: 2007
Tongue: English
Weight: 518 KB
Volume: 62
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-007-0609-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Novel treatment of ovarian cancer cell l

Novel treatment of ovarian cancer cell lines with Imatinib mesylate combined with Paclitaxel and Carboplatin leads to receptor-mediated antiproliferative effects

✍ Christoph Mundhenke; Marion Tina Weigel; Klarissa Hanja Sturner; Frank Roesel; I 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 505 KB

Antiproliferative activity of bortezomib

Antiproliferative activity of bortezomib alone and in combination with cisplatin or docetaxel in head and neck squamous cell carcinoma cell lines

✍ Jens Wagenblast; Markus Hambek; Mehran Baghi; Wolfgang Gstöttner; Klaus Strebhar 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 460 KB

Differential gene expression in a paclit

Differential gene expression in a paclitaxel-resistant clone of a head and neck cancer cell line

✍ Marianne Schmidt; Gabriele Schler; Petra Gruensfelder; Florian Hoppe 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 399 KB

Phase I/II study of S-1 combined with ca

Phase I/II study of S-1 combined with carboplatin in recurrent and/or metastatic head and neck cancer as outpatient chemotherapy

✍ Akihito Watanabe; Masanobu Taniguchi; Tetsuro Yamashita; Michihiro Ueda; Tatsuya 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## Abstract ## Background. The aims of this study were to determine the recommended dose (RD) in combination chemotherapy of S‐1 and carboplatin in recurrent and/or metastatic head and neck cancer (phase I) and to examine response rate and toxicities at RD (phase II). ## Methods. S‐1 was given o

Effects of paclitaxel in combination wit

Effects of paclitaxel in combination with radiation on human head and neck cancer cells (ZMK-1), cervical squamous cell carcinoma (CaSki), and breast adenocarcinoma cells (MCF-7)

✍ Olivier Pradier; Margaret Rave-Fränk; Heinz Schmidberger; Michael Bömecke; Jörg 📂 Article 📅 1999 🏛 Springer-Verlag 🌐 English ⚖ 180 KB

A Phase I report of paclitaxel dose esca

A Phase I report of paclitaxel dose escalation combined with a fixed dose of carboplatin in the treatment of head and neck carcinoma

✍ Frank R. Dunphy; James H. Boyd; Han J. Kim; Cherie H. Dunphy; Bruce R. Harrison; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 2 views

Thirty-six patients with untreated Stage III/IV head and neck carcinoma were treated and were evaluable for toxicity. All patients had lesions that were